| Document Date: 2014-12-08 14:35:32
Open Document File Size: 823,44 KBShare Result on Facebook
City Reference / / Company Human Experience / Otsuka America Pharmaceutical Inc. / / Currency pence / / Event Product Issues / Product Recall / FDA Phase / / IndustryTerm healthcare professionals / injection site / machinery / needle safety device / safety device / healthcare professional / needle protection device / / MedicalCondition polyuria / schizophrenia / Seizures / Leukopenia / Dysphagia / Carcinogenesis / hyperglycemia / Neutropenia / dyslipidemia / stroke / mania / cerebrovascular disease / diabetes / Known hypersensitivity / transient ischemic attack / seizure / Orthostatic Hypotension / pain / Diabetes Mellitus / Neuroleptic Malignant Syndrome / withdrawal symptoms / Tardive Dyskinesia / Agranulocytosis / akathisia / / MedicalTreatment massage / / Organization DOSAGE AND ADMINISTRATION / FDA / / / Product CYP3A4 / symptoms / MAINTENA suspension / pre / ABILIFY / MAINTENA injection / Sterile Water for Injection / Sterile Water / for / / Technology Pharmacokinetics / Pharmacodynamics / / URL www.fda.gov/medwatch / /
SocialTag |
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ABILIFY MAINTENA safely and effectively. See full prescribing information for ABILIFY MAINTENA. ABILIFY MAINTENA® (